Sven Fraterman is a core member of Boston Consulting Group's Health Care practice specializing in biopharma, and the lead partner for the firm's Center for Oncology Insights. He focuses on R&D, medical affairs, and commercial considerations, particularly in the areas of oncology, immunology, rare diseases, and cardio-renal metabolic diseases.

Sven works with large pharmaceutical and other health care companies, and small and mid-sized biotechs. Among other engagements, he has conducted several due diligences of clinical-stage assets, worked with several clients on optimizing their portfolio and individual R&D programs, developed launch and market entry strategies, and led several operating model redesigns on company and functional levels (including commercial and R&D functions).

Before joining the firm, Sven was BU Head of Hospital, Oncology and Biosimilars, at Sandoz Switzerland, Global Director Strategic Planning at Sandoz International, International Senior Product Manager Marketing Pipeline Products at Boehringer Ingelheim, Engagement Manager at another consulting company, and a visiting scientist at the University of Pennsylvania Medical School.


  • PhD, molecular biology, European Molecular Biology Laboratory 
  • MSc, molecular medicine with a focus on pharmacology, FAU-Erlangen-Nürnberg  
  • BSc, business administration and economics, Fern Universität in Hagen